Every year a large amount of clean water turns into contaminated effluent by soil washing (SW) process. The release of this effluent has become a growing environmental threat. In this study, a sustainable approach was developed for effective removal of PAHs from contaminated soil and the effluent by integrating SW and advanced oxidation processes (AOPs) in a continuous system. In the constructed continuous system, first small amount of clean water passed through the contaminated soil to remove PAHs. Then, the polluted effluent was treated by a quick AOPs and recycled for SW processes again and again until a complete removal of PHE be achieved. The performance of the continuous system was optimized and compared with batch system (no circulation) at lab scale. In addition, a scale up modeling was developed to predict the performance of continuous system at large scale. According to the results, under the optimum conditions: Tween 80 (TW80) = 6 g/L, ultrasonic = 160 kW, UV = 30 W, O = 5 g/h and TiO = 2 g/m, the final PHE degradation efficiency of 98 % and 94 % were achieved by the continuous and batch systems after 130 and 185 min, respectively. The continuous system used 5 times less water volume than the batch system but resulted in better PAHs degradation. The scale up modeling revealed at large scale (100 kg soil), the continuous system could decrease the energy consumption and the required washing solution (water + TW80) up to 50 % and 80 %, respectively in comparison to the batch system. This work suggests a promising and practical approach for contaminated soil remediation without producing polluted water.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.watres.2024.121563 | DOI Listing |
Head Neck
January 2025
Department of Pathology, All India Institute of Medical Sciences, Rishikesh, India.
Background: To correlate between immunohistochemical expression of tumor-infiltrating lymphocytes (TILs), tumor-associated macrophages (TAMs), and natural killer (NK) cells with the AJCC 8th edition TNM staging system and other disease-modifying clinico-pathological variables.
Methods: The representative histology sections of tumor invasive margin (IM) and tumor core (TC) were selected according to the International Immuno-Oncology Biomarker Working Group and were subjected to immunohistochemistry with antibodies for TILs (CD3, CD8, FOXP3), NK Cells (CD57), TAMs (CD68, CD163) and pan-leukocyte marker (CD45). Histo-immuno-density-intensity (HIDI) scoring was calculated as a product of the proportion and intensity of staining.
Biomark Res
January 2025
BK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, Department of Biomedical Sciences, School of Medicine, Kyungpook National University, Daegu, 41944, Korea.
Macrophages are pivotal in the body's defense and response to inflammation. They are present in significant numbers and are widely implicated in various diseases, including cancer. While molecular and histological techniques have advanced our understanding of macrophage biology, their precise function within the cancerous microenvironments remains underexplored.
View Article and Find Full Text PDFCurr Oncol Rep
January 2025
Medical College of Georgia of the University System of Georgia, 2 Oceans West Blvd, Daytona Beach Shores, FL, 32118, USA.
Background: Disease-focus management of late-stage cancer without addressing patients' preferences or quality of life (QoL) can lead to unsatisfactory patient and disease outcomes.
Methods: A PRISMA-adherent systematic review of the literature was conducted via PubMed, Embase, Scopus, and Google Scholar to assess the current late-stage cancer treatment modality, setting, timing, and cost, their impact on patient and disease outcomes, and possible interventions for improvement.
Results: Out of many studies, twelve from North America, Western Europe, and Asia met our inclusion criteria.
Acta Med Indones
October 2024
Faculty of Public Health, Universitas Indonesia, Depok, Indonesia.
The burden of undiagnosed diabetes mellitus (DM) is substantial, with approximately 240 million individuals globally unaware of their condition, disproportionately affecting low- and middle-income countries (LMICs), including Indonesia. Without screening, DM and its complications will impose significant pressure on healthcare systems. Current clinical practices for screening and diagnosing DM primarily involve blood or laboratory-based testing which possess limitations on access and cost.
View Article and Find Full Text PDFHandb Clin Neurol
January 2025
Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; Sleep Medicine Centre, Neurology Unit, University Hospital of Rome Tor Vergata, Rome, Italy.
Obstructive sleep apnea syndrome (OSAS) significantly affects the sleep-wake circadian rhythm through intermittent hypoxia and chronic sleep fragmentation. OSAS patients often experience excessive daytime sleepiness, frequent awakenings, and sleep fragmentation, leading to a disrupted circadian rhythm and altered sleep-wake cycle. These disruptions may exacerbate OSAS symptoms and contribute to neurodegenerative processes, particularly through the modulation of clock gene expression such as CLOCK, BMAL1, and PER.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!